Cargando…

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study

SIMPLE SUMMARY: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer, with a high recurrence rate. Since treatment of BRCA(mut) TNBC patients with PARP inhibitor (PARPi), targeting the nuclear protein PARP1, shows varied responses, its therapeutic efficacy is currently eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankaranarayanan, Ramya Ambur, Peil, Jennifer, Vogg, Andreas T. J., Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Maurer, Jochen, Mottaghy, Felix, Morgenroth, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750932/ https://www.ncbi.nlm.nih.gov/pubmed/35008392 http://dx.doi.org/10.3390/cancers14010230

Ejemplares similares

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023)

PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2022)

Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023)

Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
por: Morgenroth, Agnieszka, et al.
Publicado: (2019)

Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2020)

Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels: A New Approach toward Cell-Mediated Delivery
por: Morgenroth, Agnieszka, et al.
Publicado: (2023)

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
por: Sobolev, Alexander S.
Publicado: (2018)

New Kids on the Block: Bile Salt Conjugates of Microbial Origin
por: Ay, Ümran, et al.
Publicado: (2022)

Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
por: Rigby, Alex, et al.
Publicado: (2021)

PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
por: Riad, Aladdin, et al.
Publicado: (2020)

Hedgehog signaling sensitizes Glioma stem cells to endogenous nano-irradiation
por: Morgenroth, Agnieszka, et al.
Publicado: (2014)

In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
por: Osytek, Katarzyna M., et al.
Publicado: (2021)

Abundance of molecular triple ionization by double Auger decay
por: Roos, A. Hult, et al.
Publicado: (2018)

Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
por: Sreekumar, Sreeja, et al.
Publicado: (2023)

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
por: Idrissou, Malick Bio, et al.
Publicado: (2021)

Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10
por: Korn, Patricia, et al.
Publicado: (2021)

Radioiodinated indomethacin amide for molecular imaging of cyclooxygenase-2 expressing tumors
por: Morgenroth, Agnieszka, et al.
Publicado: (2017)

Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.
por: Neshasteh-Riz, A., et al.
Publicado: (1997)

Spectro Auger
Publicado: (1995)

Antitumor Activity of Auger Electron Emitter (111)In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
por: Rosenkranz, Andrey A., et al.
Publicado: (2018)

[(123)I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
por: Chan, Chung Ying, et al.
Publicado: (2023)

Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging Target
por: Heesch, Amelie, et al.
Publicado: (2020)

The Pierre Auger project
por: Mantsch, P M
Publicado: (1996)

The Pierre Auger Observatory
por: Swain, J D
Publicado: (2003)

Observatoire Pierre Auger
Publicado: (2009)

The theory of Auger transitions
por: Chattarji, D
Publicado: (1976)

Auger Prime Symposium
Publicado: (2015)

Horizontal auger boring projects
por: Atalah, Alan, et al.
Publicado: (2017)

Pierre Auger 1899-1993
Publicado: (1994)

Auger Physicists visit CMS
por: Hoch, Michael
Publicado: (2012)

The Pierre Auger Observatory Project
por: Niechciol, M, et al.
Publicado: (2002)

Pierre Auger (left) with Massey
por: CERN PhotoLab
Publicado: (1960)

Auger effect in mesonic atoms
por: Ferrell, R A
Publicado: (1960)

Pierre Auger with Monique Bonaudi
por: CERN PhotoLab
Publicado: (1960)

Radionuclide tumor necrosis factor-alpha activity in herniated lumbar disc correlates with severe leg pain
por: Andrade, Pablo, et al.
Publicado: (2020)

Dual addressing of thymidine synthesis pathways for effective targeting of proliferating melanoma
por: Miran, Tara, et al.
Publicado: (2017)

Sodium [(18)F]Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment
por: Florea, Alexandru, et al.
Publicado: (2021)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Cosmic rays: Auger project site
Publicado: (1996)

The future’s bright for the Pierre Auger Observatory
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_28dcigbqjj8m055cljv0b7i6gc